Title : [Relevance between TOP2A, EGFR gene expression and efficacy of docetaxel plus epirubicin as neoadjuvant chemotherapy in triple negative breast cancer patients].

Pub. Date : 2016 Mar 29

PMID : 27045718






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To retrospectively analyze the relevance between DNA topoisomerase II alpha (TOP2A), epidermal growth factor receptor (EGFR) gene expression and efficacy of docetaxel plus epirubicin as neoadjuvant chemotherapy in triple negative breast cancer (TNBC) patients. Epirubicin epidermal growth factor receptor Homo sapiens
2 OBJECTIVE: To retrospectively analyze the relevance between DNA topoisomerase II alpha (TOP2A), epidermal growth factor receptor (EGFR) gene expression and efficacy of docetaxel plus epirubicin as neoadjuvant chemotherapy in triple negative breast cancer (TNBC) patients. Epirubicin epidermal growth factor receptor Homo sapiens
3 CONCLUSIONS: Efficacy of docetaxel plus epirubicin as neoadjuvant chemotherapy in TNBC patients can be predicted by detecting TOP2A, EGFR gene expression. Epirubicin epidermal growth factor receptor Homo sapiens